Dousheng Bai

2.0k total citations
91 papers, 1.3k citations indexed

About

Dousheng Bai is a scholar working on Hepatology, Surgery and Molecular Biology. According to data from OpenAlex, Dousheng Bai has authored 91 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Hepatology, 30 papers in Surgery and 28 papers in Molecular Biology. Recurrent topics in Dousheng Bai's work include Hepatocellular Carcinoma Treatment and Prognosis (25 papers), Liver Disease and Transplantation (24 papers) and Liver Disease Diagnosis and Treatment (22 papers). Dousheng Bai is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (25 papers), Liver Disease and Transplantation (24 papers) and Liver Disease Diagnosis and Treatment (22 papers). Dousheng Bai collaborates with scholars based in China, India and United States. Dousheng Bai's co-authors include Guo‐Qing Jiang, Shengjie Jin, Jianjun Qian, Jia Fan, Ai‐Wu Ke, Ping Chen, Chi Zhang, Jie Yao, Jian Zhou and Guo‐Ming Shi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

Dousheng Bai

84 papers receiving 1.3k citations

Peers

Dousheng Bai
Shunli Shen China
Zhengfeng Yin China
Maarten W. Nijkamp Netherlands
Chengjun Sui China
Florian Castet Spain
Allyson J. Ocean United States
Kang–Da Liu China
Weikai Xiao China
Gennaro Gadaleta‐Caldarola Italy
Shunli Shen China
Dousheng Bai
Citations per year, relative to Dousheng Bai Dousheng Bai (= 1×) peers Shunli Shen

Countries citing papers authored by Dousheng Bai

Since Specialization
Citations

This map shows the geographic impact of Dousheng Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dousheng Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dousheng Bai more than expected).

Fields of papers citing papers by Dousheng Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dousheng Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dousheng Bai. The network helps show where Dousheng Bai may publish in the future.

Co-authorship network of co-authors of Dousheng Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Dousheng Bai. A scholar is included among the top collaborators of Dousheng Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dousheng Bai. Dousheng Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Huanxiang, Xin Jin, Guoqing Jiang, et al.. (2025). TRIM29 reverses lenvatinib resistance in liver cancer cells by ubiquitinating and degrading YBX1 to inhibit the PI3K/AKT pathway. Translational Oncology. 53. 102294–102294. 4 indexed citations
2.
Liu, Huanxiang, Rui Peng, Chen Chen, et al.. (2024). Effects of Indocyanine Green (ICG) Imaging-Assisted Cholecystectomy on Intraoperative and Postoperative Complications: A meta-Analysis. Surgical Innovation. 31(4). 362–372. 5 indexed citations
3.
Chen, Chen, Rui Peng, Shengjie Jin, et al.. (2024). Identification of potential biomarkers for hepatocellular carcinoma based on machine learning and bioinformatics analysis. Discover Oncology. 15(1). 808–808. 1 indexed citations
4.
Peng, Rui, et al.. (2024). Degradation of PARP1 by MARCHF3 in tumor cells triggers cCAS-STING activation in dendritic cells to regulate antitumor immunity in hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 12(11). e010157–e010157. 8 indexed citations
5.
Zhou, Jie, Rui Peng, Hao Tang, et al.. (2023). RNF173 suppresses RAF/MEK/ERK signaling to regulate invasion and metastasis via GRB2 ubiquitination in Hepatocellular Carcinoma. Cell Communication and Signaling. 21(1). 224–224. 17 indexed citations
6.
Gao, Tianming, Shengjie Jin, Jianjun Qian, et al.. (2023). The decreased risk of hepatocellular carcinoma in hepatitis B virus-related cirrhotic portal hypertension patients after laparoscopic splenectomy and azygoportal disconnection. Surgical Endoscopy. 37(11). 8522–8531. 2 indexed citations
7.
8.
9.
Wu, Long‐Fei, Dousheng Bai, Shengjie Jin, et al.. (2020). Novel noninvasive liver fibrotic markers to predict postoperative re-bleeding after laparoscopic splenectomy and azygoportal disconnection: a 1-year prospective study. Surgical Endoscopy. 35(11). 6158–6165. 4 indexed citations
10.
Yan, Bing, Dousheng Bai, Chi Zhang, et al.. (2020). Characteristics and risk differences of different tumor sizes on distant metastases of hepatocellular carcinoma: A retrospective cohort study in the SEER database. International Journal of Surgery. 80. 94–100. 20 indexed citations
11.
Bai, Dousheng, et al.. (2019). Effects of laparoscopic splenectomy and azygoportal disconnection on liver synthesis function and cirrhosis: a 2-year prospective study. Surgical Endoscopy. 34(11). 5074–5082. 16 indexed citations
12.
Peng, Rui, Pengfei Zhang, Xuan Yang, et al.. (2019). Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 38(1). 113–113. 45 indexed citations
13.
Peng, Rui, Xiaoyong Huang, Chi Zhang, et al.. (2017). Overexpression of UHRF2 in intrahepatic cholangiocarcinoma and its clinical significance. OncoTargets and Therapy. Volume 10. 5863–5872. 18 indexed citations
14.
Bai, Dousheng, et al.. (2016). Individualized Laparoscopic Therapy for Portal Hypertension: A Preliminary Single Center Experience. Journal of Laparoendoscopic & Advanced Surgical Techniques. 27(2). 121–127.
15.
Jiang, Guo‐Qing, Dousheng Bai, Ping Chen, et al.. (2016). Risk Factors for Portal Vein System Thrombosis After Laparoscopic Splenectomy in Cirrhotic Patients with Hypersplenism. Journal of Laparoendoscopic & Advanced Surgical Techniques. 26(6). 419–423. 22 indexed citations
16.
17.
Bai, Dousheng, Wei Zhao, Guo‐Qing Jiang, Jianjun Qian, & Ping Chen. (2015). Synchronous laparoscopic hepatectomy combined with splenectomy for the treatment of hepatocellular carcinoma associated with cirrhotic portal hypertensive hypersplenism. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 14(9). 750–754. 1 indexed citations
18.
Bai, Dousheng, Guo‐Qing Jiang, Jianjun Qian, et al.. (2015). Warfarin preventing portal vein thrombosis in liver cirrhotic patients after laparoscopic splenectomy. Zhonghua putong waike zazhi. 30(9). 704–706. 1 indexed citations
19.
Jiang, Guo‐Qing, et al.. (2015). One stage laparoscopic splenectomy plus portaazygous disconnection and hepatectomy. Zhonghua putong waike zazhi. 30(11). 866–869. 1 indexed citations
20.
Ke, Ai‐Wu, Guo‐Ming Shi, Jian Zhou, et al.. (2008). Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma #. Hepatology. 49(2). 491–503. 184 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shunli Shen Breakdown of academic impact, for papers by Zhengfeng Yin Breakdown of academic impact, for papers by Maarten W. Nijkamp Breakdown of academic impact, for papers by Chengjun Sui Breakdown of academic impact, for papers by Florian Castet Breakdown of academic impact, for papers by Allyson J. Ocean Breakdown of academic impact, for papers by Kang–Da Liu Breakdown of academic impact, for papers by Weikai Xiao Breakdown of academic impact, for papers by Gennaro Gadaleta‐Caldarola
Rankless by CCL
2026